𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Safety of immunomodulatory therapy in patients with bronchiectasis associated with rheumatic disease and IBD: a retrospective and cohort analysis

✍ Scribed by Pieter C. Goeminne; Patrick Verschueren; Hans Scheers; Lieven J. Dupont


Publisher
Springer
Year
2011
Tongue
English
Weight
165 KB
Volume
31
Category
Article
ISSN
0770-3198

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Seroreactivity to microbial components i
✍ Maria Papp; Istvan Altorjay; Gary L. Norman; Zakera Shums; Karoly Palatka; Zsuzs πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 137 KB πŸ‘ 2 views

Background: Antibodies directed against Saccharomyces cerevisiae (ASCA), perinuclear components of neutrophils (pANCA), and porin protein C of Escherichia coli (anti-OmpC) are reported to be associated with disease phenotype and may be of diagnostic importance in inflammatory bowel disease (IBD). Si

Long-term ursodeoxycholic acid therapy i
✍ Shinji Tomida; Masato Abei; Takashi Yamaguchi; Yasushi Matsuzaki; Junichi Shoda; πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 80 KB πŸ‘ 1 views

Whether ursodeoxycholic acid (UDCA) therapy alters the long-term clinical course of gallstones (GS) without stone dissolution remains unknown. We aimed to clarify the relationship between long-term UDCA therapy and risks of biliary pain or acute cholecystitis in GS patients. We also aimed to identif

Echocardiographic abnormalities in a coh
✍ Xuan-Hua Yu; Yi-Nong Li πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 113 KB

## Abstract ## Objective. To investigate echocardiographic abnormalities in a cohort of Chinese patients with systemic lupus erythematosus (SLE). ## Methods. Eighty‐five SLE patients who were hospitalized at our institution from January 2008 to June 2009 were included. Their clinical manifestati

Discontinuation of antiplatelet therapy
✍ Daniel J. Brotman; Mihir Bakhru; Wael Saber; Ashish Aneja; Deepak L. Bhatt; Kath πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 86 KB

## Abstract ## BACKGROUND Drug‐eluting coronary stents (DESs) pose a challenge in the perioperative period. Sirolimus and paclitaxel may inhibit reendothelialization of the traumatized vessel, making it vulnerable to platelet‐mediated thrombosis. Given the anecdotal evidence and case series sugges